Skip to main content
. 2022 Jan 17;200:428–437. doi: 10.1016/j.ijbiomac.2022.01.094

Table 1.

Patients sample used in the study.

S. No. Sample type Category Number
1. Pre-epidemic samples (before 2018) Negative 40
2. Positive sample (RT-PCR Confirmed) Group 1 (COVID-19) 70
3. COVID-19 associated mucormycosis
(RT-PCR confirmed)
Group 2 (COVID-19) 30
Total 140